Utility of Radiation After Neoadjuvant Chemotherapy for Surgically Resectable Esophageal Cancer

被引：0
|
作者：
Macedo, F. [1 ]
Azab, B. [1 ]
Song, N. [1 ]
Yakoub, D. [1 ]
Merchant, N. [1 ]
Franceschi, D. [1 ]
Livingstone, A. S. [1 ]
机构：
[1] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
66
引用
收藏
页码：S28 / S29
页数：2
相关论文
共 50 条
  • [31] Neoadjuvant immunotherapy for resectable esophageal cancer: A review
    Li, Qing
    Liu, Ting
    Ding, Zhenyu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] Efficacy and safety of neoadjuvant immunotherapy in surgically resectable esophageal cancer: A systematic review and meta-analysis
    Wang, Zhaoyang
    Shao, Changjian
    Wang, Yuanyong
    Duan, Hongtao
    Pan, Minghong
    Zhao, Jinbo
    Wang, Jian
    Ma, Zhiqiang
    Li, Xiaofei
    Yan, Xiaolong
    INTERNATIONAL JOURNAL OF SURGERY, 2022, 104
  • [33] Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study
    Ohnuma, Hiroyuki
    Sato, Yasushi
    Hayasaka, Naotaka
    Matsuno, Teppei
    Fujita, Chisa
    Sato, Masanori
    Osuga, Takahiro
    Hirakawa, Masahiro
    Miyanishi, Koji
    Sagawa, Tamotsu
    Fujikawa, Koshi
    Ohi, Motoh
    Okagawa, Yutaka
    Tsuji, Yasushi
    Hirayama, Michiaki
    Ito, Tatsuya
    Nobuoka, Takayuki
    Takemasa, Ichiro
    Kobune, Masayoshi
    Kato, Junji
    CANCER SCIENCE, 2018, 109 (11): : 3554 - 3563
  • [34] Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer
    Hayata, Keiji
    Ojima, Toshiyasu
    Nakamori, Mikihito
    Nakamura, Masaki
    Katsuda, Masahiro
    Kitadani, Junya
    Takeuchi, Akihiro
    Tabata, Hirotaka
    Maruoka, Shinpei
    Yamaue, Hiroki
    ANTICANCER RESEARCH, 2018, 38 (09) : 5267 - 5273
  • [35] Neoadjuvant chemotherapy of esophageal cancer
    Ribeiro, M.
    Povoa, S.
    Tavares, N.
    Marques, C.
    Fernandes, C.
    Almeida, D.
    Augusto, I.
    ANNALS OF ONCOLOGY, 2016, 27 : 23 - 23
  • [36] Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma
    Okamura, A.
    Watanabe, M.
    Mine, S.
    Kurogochi, T.
    Yamashita, K.
    Hayami, M.
    Imamura, Y.
    Ogura, M.
    Ichimura, T.
    Takahari, D.
    Chin, K.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (09): : 1 - 8
  • [37] Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer
    Mellon, Eric A.
    Strom, Tobin J.
    Hoffe, Sarah E.
    Frakes, Jessica M.
    Springett, Gregory M.
    Hodul, Pamela J.
    Malafa, Mokenge P.
    Chuong, Michael D.
    Shridhar, Ravi
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (04) : 547 - +
  • [38] Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer
    Keedy V.L.
    Berlin J.
    Current Treatment Options in Oncology, 2006, 7 (5) : 381 - 388
  • [39] PRIMARY CHEMOTHERAPY IN SURGICALLY RESECTABLE BREAST-CANCER
    BONADONNA, G
    VALAGUSSA, P
    ZUCALI, R
    SALVADORI, B
    CA-A CANCER JOURNAL FOR CLINICIANS, 1995, 45 (04) : 227 - 243
  • [40] Benefit of neoadjuvant chemotherapy for resectable gastric cancer
    Chorna, N.
    Lukashenko, A.
    Ostapenko, Y.
    Kolesnik, O.
    Boiko, A.
    ANNALS OF ONCOLOGY, 2018, 29
12345